Cited Articles for PMCID: 2707844

Year	Number of Results
1952	1
1988	1
1989	1
1996	1
1997	2
1998	5
1999	2
2000	10
2001	3
2002	11
2003	11
2004	6
2005	3
2006	2
2007	1
2024	0

1

Effects of gender on nigral gene expression and parkinson disease.

Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG. Cantuti-Castelvetri I, et al. Neurobiol Dis. 2007 Jun;26(3):606-14. doi: 10.1016/j.nbd.2007.02.009. Epub 2007 Mar 3. Neurobiol Dis. 2007. PMID: 17412603 Free PMC article.

2

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.

Kontopoulos E, Parvin JD, Feany MB. Kontopoulos E, et al. Hum Mol Genet. 2006 Oct 15;15(20):3012-23. doi: 10.1093/hmg/ddl243. Epub 2006 Sep 7. Hum Mol Genet. 2006. PMID: 16959795

3

alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.

Wang CK, Chen CM, Chang CY, Chang KH, Chen IC, Li ML, Lee-Chen GJ, Wu YR. Wang CK, et al. J Neural Transm (Vienna). 2006 Oct;113(10):1425-33. doi: 10.1007/s00702-006-0435-4. Epub 2006 Apr 11. J Neural Transm (Vienna). 2006. PMID: 16604306

4

Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.

von Bohlen und Halbach O, Minichiello L, Unsicker K. von Bohlen und Halbach O, et al. FASEB J. 2005 Oct;19(12):1740-2. doi: 10.1096/fj.05-3845fje. Epub 2005 Jul 21. FASEB J. 2005. PMID: 16037097

5

Considerations when using the significance analysis of microarrays (SAM) algorithm.

Larsson O, Wahlestedt C, Timmons JA. Larsson O, et al. BMC Bioinformatics. 2005 May 29;6:129. doi: 10.1186/1471-2105-6-129. BMC Bioinformatics. 2005. PMID: 15921534 Free PMC article.

6

Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

Tamás A, Lubics A, Szalontay L, Lengvári I, Reglodi D. Tamás A, et al. Behav Brain Res. 2005 Mar 30;158(2):221-9. doi: 10.1016/j.bbr.2004.09.002. Behav Brain Res. 2005. PMID: 15698888

7

alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J, Van Broeckhoven C, Farrer MJ. Pals P, et al. Ann Neurol. 2004 Oct;56(4):591-5. doi: 10.1002/ana.20268. Ann Neurol. 2004. PMID: 15455394

8

A benchmark for Affymetrix GeneChip expression measures.

Cope LM, Irizarry RA, Jaffee HA, Wu Z, Speed TP. Cope LM, et al. Bioinformatics. 2004 Feb 12;20(3):323-31. doi: 10.1093/bioinformatics/btg410. Bioinformatics. 2004. PMID: 14960458

9

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG. Zarranz JJ, et al. Ann Neurol. 2004 Feb;55(2):164-73. doi: 10.1002/ana.10795. Ann Neurol. 2004. PMID: 14755719

10

Guideline to reference gene selection for quantitative real-time PCR.

Radonić A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A. Radonić A, et al. Biochem Biophys Res Commun. 2004 Jan 23;313(4):856-62. doi: 10.1016/j.bbrc.2003.11.177. Biochem Biophys Res Commun. 2004. PMID: 14706621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year